Gossamer Bio Inc. (GOSS) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
Tweet
Share
E-mailGet Alerts GOSS Hot Sheet
Join SI Premium – FREE
Gossamer Bio Inc. (NASDAQ: GOSS) reported Q3 EPS of ($0.14), $0.01 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $9.48 million versus the consensus estimate of $8.53 million.
For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Crown Holdings (CCK) Tops Q3 EPS by 13c; offers guidance
- FreightCar America cuts 2026 outlook after tank car order removal
- U.S. to announce certification of Boeing 737 Max 10 on Tuesday - Reuters
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
